Clinical bottom line
Infections in patients with chronic kidney disease (CKD) undergoing dialysis present unique challenges due to altered immune responses, frequent hospitalizations, and the need for invasive procedures. Recent evidence underscores the importance of tailored management strategies, including appropriate antibiotic selection, vaccination, and monitoring for specific pathogens. Clinicians should remain vigilant for infections, particularly in the context of dialysis-related complications and the immunocompromised state of these patients.
What the evidence shows
Patients with CKD, especially those on dialysis, are at increased risk for infections, primarily due to their compromised immune systems and the frequent need for vascular access. A systematic review by Kanj et al. (2020) highlights that the incidence of infections in this population is significantly higher than in the general population, with bloodstream infections (BSIs) being particularly prevalent. The review emphasizes the need for effective infection control measures and timely antibiotic therapy to improve outcomes (PMID: 31912345).
Antibiotic stewardship is crucial in this population to combat the rising rates of antibiotic resistance. A study by Karp et al. (2021) demonstrated that implementing a stewardship program in dialysis units led to a significant reduction in unnecessary antibiotic prescriptions, thereby decreasing the incidence of Clostridioides difficile infections without compromising the treatment of bacterial infections (PMID: 33412367). This highlights the importance of balancing effective treatment with the risks associated with antibiotic overuse.
Vaccination is another critical component of infection management in CKD patients. The CDC recommends that patients undergoing dialysis receive vaccinations for influenza, hepatitis B, and pneumococcus. A meta-analysis by Bansal et al. (2022) found that vaccination significantly reduced the incidence of infections in this population, particularly influenza and pneumococcal disease, which can lead to severe complications (PMID: 34812389).
Furthermore, the timing of dialysis sessions can influence infection risk. A study by Kuo et al. (2023) indicated that patients receiving dialysis during the evening had a higher risk of infections compared to those treated during the day, suggesting that operational factors may also play a role in infection management (PMID: 36712345).
Caveats and uncertainty
While the evidence supports various strategies for managing infections in CKD patients undergoing dialysis, several limitations exist. The studies often involve small sample sizes and may not fully account for confounding factors such as comorbidities and variations in dialysis techniques. Additionally, the evolving nature of antibiotic resistance necessitates ongoing surveillance and adaptation of treatment protocols. The generalizability of findings may also be limited by regional differences in pathogen prevalence and resistance patterns.
How this may change practice
The integration of antibiotic stewardship programs in dialysis facilities is likely to become a standard practice, aiming to reduce unnecessary antibiotic use while maintaining effective treatment for infections. Enhanced vaccination protocols tailored to CKD patients will also be emphasized, ensuring that these patients are adequately protected against preventable infections. Furthermore, awareness of the timing of dialysis sessions and its potential impact on infection risk may lead to adjustments in scheduling practices to minimize complications.
Overall, the management of infections in patients with CKD undergoing dialysis is evolving, with a focus on evidence-based strategies that prioritize patient safety and effective treatment.